每日服用的减肥药司美格鲁肽片(Wegovy)即将在澳大利亚药房上架
Published
一种新的减肥药很快将可供澳大利亚人使用。该国药品监管机构治疗用品管理局(TGA)已批准Wegovy的片剂版本。Wegovy是一种GLP-1类药物,这类药物能让人更长时间感到饱腹,并可以减少进食量。
到目前为止,GLP-1类治疗大多以每周注射的方式进行。新版本则是每天服用一粒药片。报道称,澳大利亚人总共将有两种每日服用的GLP-1药片可供选择,这让患者在治疗方式上有了更多选择。该药预计本周将出现在药房货架上,不过具体价格以及政府补贴如何覆盖费用,在最初的报道中并未确定。
医生通常建议将GLP-1类药物与健康饮食和规律运动结合使用。考虑服用这种药片的患者,在开始治疗前应先咨询医生或药剂师,因为这种药并非适合所有人,并且可能产生副作用。TGA的批准意味着该药片在澳大利亚销售之前,已经过安全性和质量检查。
Sources: Nine.com.au
More Australia news
- Bunnings to Cut 230 Jobs as Part of Technology Shift Overseas
- Bunnings Cuts 350 Tech Jobs as AI Takes On More Office Tasks
- Bunnings Cuts a Third of Its IT Staff as Tata Consultancy Services Takes Over Work
- Australia Joins US-Led AI Security Agreement to Protect Supply Chains and Critical Infrastructure
- Bunnings Cuts 350 Tech Jobs as Work Moves Offshore
- Victoria's Party Leaders Face Off in Live People's Forum Before November Election
- Backpackers Face Longer Regional Work Requirement for Second Year Visa
- Government Initiative Sets Record for Aboriginal Businesses